# Starling Oncology, Inc.: Form 8-K, filed Sep 2, 2026

- Company: [Starling Oncology, Inc.](/companies/stln.md) (CIK 1799191)
- Form: 8-K
- Filed: 2026-09-02
- Accepted by EDGAR: Sep 1, 2026, 20:41 ET
- Period: 2026-09-01
- Accession: 0001079973-26-001208
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1799191/000107997326001208/stln_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799191/000107997326001208/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799191/000107997326001208/stln_8k.htm

Filed Sep 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001079973-26-001208. Last ingested by Listed: Nov 15, 2026, 04:34 ET. No prices; not investment advice.
